These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9446007)

  • 21. Beneficial role of intravenous calcitriol on bone mineral density in children with severe secondary hyperparathyroidism.
    Baskin E; Ozen S; Karçaaltincaba M; Besbas N; Saatci U; Düzova A; Agras PI; Haliloglu M; Bakkaloglu A
    Int Urol Nephrol; 2004; 36(1):113-8. PubMed ID: 15338687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous versus oral calcitriol therapy in renal osteodystrophy: results of a prospective, pulsed and dose-comparable study.
    Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Di Sanza P; Sardella D; Taggi F; Coen G
    Miner Electrolyte Metab; 1994; 20(3):122-9. PubMed ID: 7816000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effect of oral calcitriol single weekly pulse in CAPD and in HD.
    Romanini D; Gazo A; Bellazzi R; de Vincenzi A; Nai M; Santagostino M
    Adv Perit Dial; 1994; 10():267-9. PubMed ID: 7999842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of small doses of calcitriol in hemodialysis patients with moderate secondary hyperparathyroidism.
    Vlassopoulos D; Noussias C; Revenas K; Hadjilouka-Mantaka A; Arvanitis D; Tzortzis G; Hadjiconstantinou V
    Ren Fail; 1999 Mar; 21(2):199-207. PubMed ID: 10088180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective treatment of secondary hyperparathyroidism in hemodialysis patients by titration of intravenous calcitriol dosage.
    Grekas D; Balaskas E; Kampouris H; Benos A; Konstantinou A; Sioullis A; Tourkantonis A
    Clin Nephrol; 1999 Sep; 52(3):167-71. PubMed ID: 10499312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of cinacalcet combined with low-dose calcitriol on clinical outcome and bone metabolism in patients with severe secondary hyperparathyroidism].
    Yuan F; Chen X; Wang C; Zhou A; Liu H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 42(10):1169-1173. PubMed ID: 29093248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low calcium dialysate and high-dose oral calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis patients.
    Van der Merwe WM; Rodger RS; Grant AC; Logue FC; Cowan RA; Beastall GH; Junor BJ; Briggs JD
    Nephrol Dial Transplant; 1990; 5(10):874-7. PubMed ID: 2128383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of secondary hyperparathyroidism during oral calcitriol therapy in pediatric renal osteodystrophy.
    Goodman WG; Salusky IB
    Contrib Nephrol; 1991; 90():189-95. PubMed ID: 1959345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
    Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
    Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients.
    Tamura S; Ueki K; Mashimo K; Tsukada Y; Naitoh M; Abe Y; Kawai H; Tsuchida A; Wakamatsu R; Nojima Y
    Clin Exp Nephrol; 2005 Sep; 9(3):238-43. PubMed ID: 16189633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose alfacalcidol controls secondary hyperparathyroidism in predialysis chronic kidney disease.
    Reichel H
    Nephron Clin Pract; 2010; 114(4):c268-76. PubMed ID: 20090369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients.
    Zheng CM; Wu CC; Hung CF; Liao MT; Shyu JF; Hsu YH; Lu CL; Wang YH; Zheng JQ; Chang TJ; Lin YF; Lu KC
    Nutrients; 2018 Feb; 10(2):. PubMed ID: 29439405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A crossover comparison of intermittent oral and intravenous administration of calcitriol on the parathyroid hormone concentration in hemodialysis patients.
    Peng SJ; Yang CS; Ferng SH; Chen LY
    Miner Electrolyte Metab; 1997; 23(1):13-8. PubMed ID: 9058364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Conversion From Parenteral Paricalcitol to Pulse Oral Calcitriol for the Management of Secondary Hyperparathyroidism in Hemodialysis Patients.
    Kumar J; Tran NT; Schomberg J; Streja E; Kalantar-Zadeh K; Pahl M
    J Ren Nutr; 2016 Jul; 26(4):265-9. PubMed ID: 27038806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial comparing pulse calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism in haemodialysis patients.
    Kiattisunthorn K; Wutyam K; Indranoi A; Vasuvattakul S
    Nephrology (Carlton); 2011 Mar; 16(3):277-84. PubMed ID: 21342321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy.
    Coen G; Mantella D; Manni M; Balducci A; Nofroni I; Sardella D; Ballanti P; Bonucci E
    Kidney Int; 2005 Oct; 68(4):1840-8. PubMed ID: 16164662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol.
    Cannella G; Bonucci E; Rolla D; Ballanti P; Moriero E; De Grandi R; Augeri C; Claudiani F; Di Maio G
    Kidney Int; 1994 Oct; 46(4):1124-32. PubMed ID: 7861707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of calcitriol on secondary hyperparathyroidism].
    Xu H; Zhang J; Cheng X; Zhou Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 38(9):920-4. PubMed ID: 24071691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.